Skip to main content

Advertisement

Log in

Liver Biopsy in the Management of Autoimmune Hepatitis Acute Severe Onset

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Czaja AJ. Acute and acute severe (Fulminant) autoimmune hepatitis. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-012-2445-4.

  2. Manns MP, Czaja AJ, Gorham JD, et al. Practice guidelines of the American association for the study of liver diseases. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193–2213.

    Article  PubMed  CAS  Google Scholar 

  3. Medina J, García-Buey L, Moreno-Otero R. Immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther. 2003;17:1–16.

    Article  PubMed  CAS  Google Scholar 

  4. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006;354:54–66.

    Article  PubMed  CAS  Google Scholar 

  5. Hennes EM, Zeniya M, Czaja AJ, et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–176.

    Article  PubMed  Google Scholar 

  6. García-Buey L, García-Monzón C, Rodriguez S, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology. 1995;108:1770–1777.

    Article  PubMed  Google Scholar 

  7. Burgart LJ, Batts KP, Ludwig J, Nikias GA, Czaja AJ. Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations. Am J Surg Pathol. 1995;19:699–708.

    Article  PubMed  CAS  Google Scholar 

  8. Czaja AJ, Carpenter HA. Optimizing diagnosis from the medical liver biopsy. Clin Gastroenterol Hepatol. 2007;5:898–907.

    Article  PubMed  Google Scholar 

  9. Björnsson E, Talwalkar J, Treeprasertsuk S, Neuhauser M, Lindor K. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol. 2011;9:57–63.

    Article  PubMed  Google Scholar 

  10. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958–976.

    Article  PubMed  CAS  Google Scholar 

  11. Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol. 2010;51:2040–2048.

    Article  Google Scholar 

  12. Björnsson E, Talwalkar J, Treeprasertuks S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51:204–208.

    Article  Google Scholar 

  13. Sanz-Cameno P, Medina J, García-Buey L, et al. Enhanced intrahepatic inducible nitric oxide synthase expresión and nitrotyroxine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol. 2002;37:723–729.

    Article  PubMed  CAS  Google Scholar 

  14. Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci. 2011;56:545–554.

    Article  PubMed  CAS  Google Scholar 

  15. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540–1548.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ricardo Moreno-Otero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno-Otero, R. Liver Biopsy in the Management of Autoimmune Hepatitis Acute Severe Onset. Dig Dis Sci 58, 1808–1810 (2013). https://doi.org/10.1007/s10620-013-2662-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2662-5

Keywords

Navigation